Lipigon Pharmaceuticals AB (publ) (LPGO.ST)
SEK 0.13
(2.42%)
SEK 0.13
(2.42%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -1.62 Million SEK | 0.0% |
| 2022 | - SEK | 0.0% |
| 2021 | - SEK | 0.0% |
| 2020 | - SEK | -100.0% |
| 2019 | 1.00 SEK | 100.0% |
| 2018 | -117.41 Million SEK | -66614.58% |
| 2017 | -175.99 Thousand SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - SEK | 100.0% |
| 2024 Q2 | 1000.00 SEK | 0.0% |
| 2023 Q1 | -432.99 Thousand SEK | 0.0% |
| 2023 Q3 | - SEK | 0.0% |
| 2023 FY | -1.62 Million SEK | 0.0% |
| 2023 Q4 | -1.62 Million SEK | 0.0% |
| 2023 Q2 | - SEK | 100.0% |
| 2022 Q3 | - SEK | 100.0% |
| 2022 Q1 | -103 Thousand SEK | 0.0% |
| 2022 FY | - SEK | 0.0% |
| 2022 Q4 | - SEK | 0.0% |
| 2022 Q2 | -103 Thousand SEK | 0.0% |
| 2021 Q1 | -927 Thousand SEK | 65.55% |
| 2021 FY | - SEK | 0.0% |
| 2021 Q4 | -103 Thousand SEK | -10300100.0% |
| 2021 Q3 | 1.00 SEK | 0.0% |
| 2021 Q2 | 1.00 SEK | 100.0% |
| 2020 FY | - SEK | -100.0% |
| 2020 Q4 | -2.69 Million SEK | 0.0% |
| 2020 Q1 | - SEK | 0.0% |
| 2019 FY | 1.00 SEK | 100.0% |
| 2018 FY | -117.41 Million SEK | -66614.58% |
| 2017 FY | -175.99 Thousand SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alzinova AB (publ) | -3.27 Million SEK | 50.397% |
| Amniotics AB (publ) | 534 Thousand SEK | 404.494% |
| Asarina Pharma AB (publ) | - SEK | Infinity% |
| BioArctic AB (publ) | - SEK | Infinity% |
| Calliditas Therapeutics AB (publ) | 20.42 Million SEK | 107.96% |
| Genovis AB (publ.) | 14.9 Million SEK | 110.909% |
| LIDDS AB (publ) | - SEK | Infinity% |
| Magle Chemoswed Holding AB (publ) | 35.22 Million SEK | 104.616% |
| OncoZenge AB (publ) | -862.99 Thousand SEK | -88.413% |
| Saniona AB (publ) | 1.00 SEK | 162600100.0% |
| Simris Alg AB (publ) | 1.09 Million SEK | 249.038% |
| Vicore Pharma Holding AB (publ) | - SEK | Infinity% |
| AcouSort AB (publ) | 2.08 Million SEK | 178.173% |
| Active Biotech AB (publ) | -2500.00 SEK | -64940.0% |
| Camurus AB (publ) | 100.95 Million SEK | 101.611% |
| Cantargia AB (publ) | - SEK | Infinity% |
| Scandinavian ChemoTech AB (publ) | 4.03 Million SEK | 140.307% |
| Guard Therapeutics International AB (publ) | -1486.00 SEK | -109321.265% |
| Mendus AB (publ) | - SEK | Infinity% |
| Kancera AB (publ) | -1950.00 SEK | -83284.615% |
| Karolinska Development AB (publ) | - SEK | Infinity% |
| Lipum AB (publ) | - SEK | Infinity% |
| NextCell Pharma AB | 545.23 Thousand SEK | 398.219% |
| Xbrane Biopharma AB (publ) | 106.85 Million SEK | 101.522% |
| Xintela AB (publ) | 398 Thousand SEK | 508.543% |
| Ziccum AB (publ) | -4.18 Million SEK | 61.184% |
| Elicera Therapeutics AB (publ) | -446.98 Thousand SEK | -263.77% |
| Modus Therapeutics Holding AB (publ) | - SEK | Infinity% |
| Isofol Medical AB (publ) | - SEK | Infinity% |
| Xspray Pharma AB (publ) | 43.78 Million SEK | 103.714% |
| CombiGene AB (publ) | -1.79 Million SEK | 9.616% |
| Diamyd Medical AB (publ) | 24.05 Million SEK | 106.761% |
| Intervacc AB (publ) | 10.48 Million SEK | 115.511% |
| Alligator Bioscience AB (publ) | 2.00 SEK | 81300100.0% |
| Sprint Bioscience AB (publ) | -7.13 Million SEK | 77.214% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | - SEK | Infinity% |
| Corline Biomedical AB | -3.85 Million SEK | 57.843% |
| IRLAB Therapeutics AB (publ) | 1000.00 SEK | 162700.0% |
| Bio-Works Technologies AB (publ) | 9.06 Million SEK | 117.931% |
| Aptahem AB (publ) | - SEK | Infinity% |
| Infant Bacterial Therapeutics AB (publ) | - SEK | Infinity% |
| Fluicell AB (publ) | 3.15 Million SEK | 151.619% |
| Biovica International AB (publ) | 2.19 Million SEK | 173.943% |
| Spago Nanomedical AB (publ) | 1.00 SEK | 162600100.0% |
| Abliva AB (publ) | - SEK | Infinity% |
| Egetis Therapeutics AB (publ) | 700 Thousand SEK | 332.286% |
| 2cureX AB (publ) | -1000.00 SEK | -162500.0% |
| I-Tech AB | 4.28 Million SEK | 137.991% |
| Hansa Biopharma AB (publ) | 9.79 Million SEK | 116.605% |
| Cyxone AB (publ) | - SEK | Infinity% |
| ExpreS2ion Biotech Holding AB (publ) | - SEK | Infinity% |
| Biosergen AB | -4.92 Million SEK | 67.012% |
| Nanologica AB (publ) | 2.97 Million SEK | 154.692% |
| SynAct Pharma AB | - SEK | Infinity% |
| Annexin Pharmaceuticals AB (publ) | - SEK | Infinity% |
| BioInvent International AB (publ) | 11.84 Million SEK | 113.728% |
| Stayble Therapeutics AB (publ) | -321.14 Thousand SEK | -406.313% |
| Oncopeptides AB (publ) | 2.42 Million SEK | 167.052% |
| Pila Pharma AB (publ) | 1.00 SEK | 162600100.0% |
| Ascelia Pharma AB (publ) | - SEK | Infinity% |
| Diagonal Bio AB (publ) | 1.02 Million SEK | 258.171% |